TeleflexLogo.jpg
Large-Scale Real-World Study Demystifies UroLift™ System Durability and Reinforces Superior Patient Experience for Men With Enlarged Prostate Compared to Leading Surgical Treatments
November 14, 2023 06:45 ET | Teleflex Incorporated
WAYNE, Pa., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, announced today that a new peer-reviewed study in the Nature...
TeleflexLogo.jpg
New Survey Highlights the Quality of Life Impact of an Enlarged Prostate
September 12, 2023 06:30 ET | Teleflex Incorporated
WAYNE, Pa., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced results of its new survey showing that symptoms...
TeleflexLogo.jpg
New Data Highlight that Early Intervention with the UroLift® System Facilitates Long-Term Outcomes for BPH Patients
May 03, 2023 06:30 ET | Teleflex Incorporated
WAYNE, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced new research findings reinforcing the long-term...
TeleflexLogo.jpg
Teleflex Launches National Ad Campaign — “Pit Stop” — to Raise Awareness of the UroLift® System as a Treatment for Enlarged Prostate
February 06, 2023 06:30 ET | Teleflex Incorporated
WAYNE, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the launch of a new national advertising campaign...
TeleflexLogo.jpg
Published Data Demonstrate Consistent PUL Outcomes for the Treatment of Median Lobe Obstruction Across Controlled and Real-World Settings
October 25, 2022 06:30 ET | Teleflex Incorporated
Men with obstructive median lobes treated with the UroLift® System experience symptom improvement sooner and are satisfied more quickly compared to those treated with TURP, and have fewer post-op...
TeleflexLogo.jpg
Teleflex Announces Collaboration with FundamentalVR, to Improve Training Through Virtual Reality Simulation
August 25, 2022 06:30 ET | Teleflex Incorporated
FundamentalVR Offers Teleflex a Scalable Training Platform to Accelerate the Effective Use of the UroLift® 2 System for Treatment of Enlarged Prostate WAYNE, Pa., Aug. 25, 2022 (GLOBE NEWSWIRE) --...
TeleflexLogo.jpg
Teleflex Announces Pocono Raceway NASCAR Event to Raise Visibility of Enlarged Prostate and the Importance of Regular Health Screenings
July 21, 2022 06:30 ET | Teleflex Incorporated
WAYNE, Pa., July 21, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the company is hosting a booth at the Pocono...
TeleflexLogo.jpg
New Data Reinforce Efficacy of the UroLift® System for the Treatment of Enlarged Prostate
July 01, 2022 06:30 ET | Teleflex Incorporated
WAYNE, Pa., July 01, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the results of several research studies that...
TeleflexLogo.jpg
Teleflex Celebrates June Men’s Health Month with Launch of UroLift® Patient Ambassador Program
June 01, 2022 06:30 ET | Teleflex Incorporated
WAYNE, Pa., June 01, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it is celebrating Men’s Health Month with the...
TeleflexLogo.jpg
Teleflex Announces Regulatory Clearance for its UroLift® System in China for the Treatment of Benign Prostatic Hyperplasia (BPH)
May 19, 2022 06:30 ET | Teleflex Incorporated
WAYNE, Pa., May 19, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it has received National Medical Products...